Search PubMed⌕ Search

Biomedical subjects

A F North

Publications and source records attributed to A F North.

At least 37 records · Page 2Linked to original sources

Current status and future role of health screening.

To date, screening has largely failed to fulfill the hope that early detection would lead to more effective early treatment and to improved health status in the population served. The future role of screening can be much more positive but only if (1) screening is directed only at diseases and conditions for which early intervention has proven benefits; (2) valid screening methods are developed and used; (3) screening is done in settings in which diagnosis and treatment are assured; and (4) there is continuing scientific evaluation of the benefits and costs of screening.

Cost-Benefit Analysis↗

The effects of anticipated funding changes on maternal and child health projects: a case study of uncertainty.

A questionnaire survey of Title V special projects--Maternal and Infant Care (M&I), Comprehensive Care for Children and Youth (C&Y), Neonatal Intensive Care and Children's Dental Care--indicated that the anticipated change from federal project grants to state formula grants caused anxiety among project directors, low morale and high turnover in project staff, difficulty in filling staff positions, and anticipation of service reductions. These effects were much more prevalent and severe in projects which could realistically be expected to suffer budget cuts as a result of the shift in funding method. Despite the widespread anxiety, low morale and adverse effects reported by program directors, there was no reduction in the number of patients served, the scope of services offered, or the number of staff employed.

Adolescent↗

Screening in child care.

For a disease to be susceptible to screening, it should be definable, important and treatable. Treatment begun earlier on the basic of discovery through screening must have some advantage. The period between first possible detection and optimal time for treatment must be substantial. Adequate facilities and resources for evaluation and care must be available. Finally, there must be a valid, low-cost test for the disease and there must not be a high cost associated with false-positive or false-negative results.

Adolescent↗